Amgen Buys a Cancer Drug Maker
Tuesday, January 25, 2011 - 01:10
in Mathematics & Economics
Amgen will pay $425 million and perhaps $575 million in milestone payments to BioVex, a maker of experimental cancer drugs.
Updated by artificial intelligence Wed, 12 Mar 2025, 23:55:19 UTC Learn more
- Tell your friends
- Get science news via